Oct 21 |
Capricor Therapeutics initiated at Overweight by Piper Sandler
|
Oct 18 |
Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
|
Oct 17 |
Capricor Therapeutics stock falls after pricing $75M equity offering
|
Oct 17 |
Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock
|
Oct 16 |
Capricor Therapeutics proposes public offering of common stock
|
Oct 16 |
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
|
Oct 14 |
Capricor touts long-term efficacy of DMD therapy ahead of FDA application
|
Oct 11 |
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,800 Today
|
Oct 11 |
Capricor reports positive long-term data for DMD drug deramiocel
|
Oct 11 |
Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years
|